SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001213900-24-005378
Filing Date
2024-01-22
Accepted
2024-01-22 17:29:40
Documents
16

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT defm14a0124_phoenix.htm DEFM14A 16948194
2 GRAPHIC tbarchart_001.jpg GRAPHIC 230395
3 GRAPHIC timage_001.jpg GRAPHIC 141728
4 GRAPHIC timage_002.jpg GRAPHIC 110756
5 GRAPHIC timage_003.jpg GRAPHIC 397561
6 GRAPHIC timage_004.jpg GRAPHIC 108424
7 GRAPHIC timage_005.jpg GRAPHIC 530583
8 GRAPHIC timage_006.jpg GRAPHIC 254992
9 GRAPHIC timage_007.jpg GRAPHIC 477278
10 GRAPHIC timage_008.jpg GRAPHIC 177991
11 GRAPHIC timage_009.jpg GRAPHIC 242405
12 GRAPHIC timage_010.jpg GRAPHIC 265141
13 GRAPHIC tlinechart_001.jpg GRAPHIC 282487
14 GRAPHIC tlinechart_002.jpg GRAPHIC 623930
15 GRAPHIC tproxy_01.jpg GRAPHIC 1469734
16 GRAPHIC tproxy_02.jpg GRAPHIC 2162020
  Complete submission text file 0001213900-24-005378.txt   27247740
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-40877 | Film No.: 24549930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)